SAM
NKTR icon

Securian Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Securian Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,099
Closed -$296K – 985
2021
Q3 		$296K Sell
1,099
-18
-2% -$4.33K 0.01% 907
2021
Q2 		$288K Sell
1,117
-29
-3% -$8.03K 0.01% 922
2021
Q1 		$344K Buy
1,146
+12
+1% +$3.73K 0.01% 881
2020
Q4 		$289K Sell
1,134
-24
-2% -$6.2K 0.01% 878
2020
Q3 		$288K Sell
1,158
-39
-3% -$12.3K 0.01% 846
2020
Q2 		$416K Sell
1,197
-7
-0.6% -$2.18K 0.01% 737
2020
Q1 		$322K Hold
1,204
– – 0.01% 758
2019
Q4 		$390K Buy
1,204
+15
+1% +$4.35K 0.01% 849
2019
Q3 		$325K Hold
1,189
– – 0.01% 891
2019
Q2 		$635K Buy
1,189
+17
+1% +$8.52K 0.01% 697
2019
Q1 		$591K Buy
1,172
+10
+0.9% +$5.93K 0.01% 718
2018
Q4 		$573K Sell
1,162
-22
-2% -$13.3K 0.02% 684
2018
Q3 		$1.08M Buy
1,184
+97
+9% +$82.8K 0.03% 549
2018
Q2 		$796K Sell
1,087
-14
-1% -$16.1K 0.02% 616
2018
Q1 		$1.75M Buy
+1,101
New +$1.42M 0.05% 369

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Securian Asset Management's NKTR Position: Q4 2021 in Review

Securian Asset Management sold out of Nektar Therapeutics (NKTR) in Q4 2021, closing a stake of 1,099 shares — an estimated $296K sold.

Securian Asset Management first reported a position in NKTR in Q1 2018 and held it in 15 quarters. The position peaked at $1.75M in Q1 2018. 240 funds tracked by Wall St. Rank hold NKTR as of Q4 2021.

  • Securian Asset Management reported no remaining Nektar Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Securian Asset Management sold 1,099 Nektar Therapeutics shares in Q4 2021, an estimated $296K.
  • Securian Asset Management first reported a position in Nektar Therapeutics in Q1 2018 and held it in 15 quarters.
  • Securian Asset Management's Nektar Therapeutics position peaked at $1.75M in Q1 2018.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2021.

Based on Securian Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.